- Home
- FA vs HCM Comparison
FA vs HCM Comparison
Compare FA & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FA | HCM |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.7B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | FA | HCM |
|---|---|---|
| Price | $13.29 | $14.76 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 4 | 1 |
| Target Price | ★ $19.00 | $13.75 |
| AVG Volume (30 Days) | ★ 630.4K | 48.9K |
| Earning Date | 02-26-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | ★ $1,461,496,000.00 | $602,197,000.00 |
| Revenue This Year | $85.07 | N/A |
| Revenue Next Year | $5.03 | $15.54 |
| P/E Ratio | ★ N/A | $5.47 |
| Revenue Growth | ★ 93.41 | N/A |
| 52 Week Low | $11.95 | $11.51 |
| 52 Week High | $20.28 | $19.50 |
Technical Indicators
Market Signals| Indicator | FA | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 42.60 | 49.60 |
| Support Level | $12.65 | $14.16 |
| Resistance Level | $14.20 | $15.82 |
| Average True Range (ATR) | 0.75 | 0.39 |
| MACD | -0.17 | -0.13 |
| Stochastic Oscillator | 32.86 | 28.11 |
Price Performance
Historical ComparisonAbout FA First Advantage Corporation
First Advantage Corp is a provider of global software and data in the Human Resources technology industry. The company leverages proprietary technology and AI across its platforms, data, and APIs to deliver comprehensive background screening, digital identity, and verification solutions driven by innovation, automation, and customer success. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. Maximum revenue is generated from the First Advantage Americas segment. The group serves customers in over 200 countries and territories, modernising hiring and onboarding on a global scale.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.